Amarin reported $4.39M in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
DBV Technologies DBVT:US USD 3.05M 2.23M
Abbvie ABBV:US USD 3.3B 174M
Alnylam Pharmaceuticals ALNY:US USD 235.86M 65.88M
Amarin AMRN:US USD 4.39M 82.51M
AstraZeneca AZN:LN USD 3.35B 280M
Biocryst Pharmaceuticals BCRX:US USD 36.92M 1.1M
Esperion Therapeutics ESPR:US USD 24.95M 4.65M
GlaxoSmithKline GSK:LN GBP 1.97B 13M
Halozyme Therapeutics HALO:US USD 34.07M 23.41M
Heron Therapeutics HRTX:US USD 28.18M 3.94M
Intercept Pharmaceuticals ICPT:US USD 43.27M 3.29M
IONIS PHARMACEUT IONS:US USD 34.42M 614K
JAZZ PHA JAZZ:US USD 317.68M 7.99M
Nektar Therapeutics NKTR:US USD 22.53M 1.09M
Neurocrine Biosciences NBIX:US USD 186.3M 3.5M
Novartis NOVN:VX USD 3.4B 185M
Teva Pharmaceutical Industries TEVA:US USD 777M 72M